Back to ProShare Advisors LLC ProShare Advisors LLC

KNSA

6 quarters

Position history for ProShare Advisors LLCProShare Advisors LLC's holdings in Kiniksa Pharmaceuticals International, plc

Yes. ProShare Advisors holds 7,408 shares of KNSA (Kiniksa Pharmaceuticals International), worth $552,710, as of its Q3 2026 13F filing. It increased the position by 338 shares (+4.8%) from Q2 2026. ProShare Advisors has held KNSA since Q2 2026, across 2 quarterly 13F filings.

Current Value

$552,710

Current Shares

7,408

Total Value Change

+$316,556

Total Shares Change

-2,042

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
7,408
+4.8%
$552,7100.0%$74.61
25
2026-Q2
New
7,070
-
$452,1270.0%$63.95
33
2025-Q2
Exited
0
-100.0%
$00.0%$27.67
0
2025-Q1
Decreased
10,225
-20.2%
$227,0970.0%$22.21
0
2024-Q4
Increased
12,807
+35.5%
$253,3230.0%$19.78
30
2024-Q3
New
9,450
-
$236,1540.0%$24.99
32

Other major holders of KNSA: FMR LLC, Baker Bros. Advisors LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used